https://bioinformatics.umg.eu/onkopus/drugon#alirocumab
Properties
- identifier
- [] wikipedia:alirocumab
- identifier
- [] pubchem substance:347910431
- label
- [] alirocumab
- identifier
- [] kegg drug:d10335
- synonym
- [] alirocumab
- identifier
- [] drugs product database (dpd):22706
- identifier
- [] chembl:chembl2109540
- identifier
- [] rxcui:1659152
Parents
Children
Relations
- has_mesh
- lipidregulatingagents
- has_mesh
- proproteinconvertasesubtilisinkexintype9pcsk9inhibitors
- has_mesh
- immunoglobulins
- has_mesh
- aminoacidspeptidesandproteins
- has_mesh
- bloodproteins
- has_mesh
- lipidmodifyingagentsplain
- has_mesh
- proteins
- has_atc
- ccardiovascularsystem
- has_atc
- c10alipidmodifyingagentsplain
- has_mesh
- nonstatinhypolipidemicagentsindicatedforhyperlipidemia
- has_mesh
- serumglobulins
- is_inhibitor_for
- pcsk9
- has_kegg_class
- cardiovascularagenthypolipidemicagent
- has_mesh
- hypolipidemicagentsindicatedforhyperlipidemia
- has_mesh
- immunoproteins
- has_mesh
- hypercholesterolemiadrugtherapy
- has_mesh
- anticholesteremicagents
- has_mesh
- pcsk9inhibitor
- has_mesh
- hypolipidemicagents
- has_mesh
- antimetabolites
- has_mesh
- lipidmodifyingagents
- has_mesh
- antibodies
- has_kegg_group
- hypolipidemicagenthypolipidemicagent
- has_mesh
- globulins
- has_mesh
- antibodiesmonoclonal
- has_atc
- c10lipidmodifyingagents
- has_mesh
- proteaseinhibitors
- has_mesh
- enzymeinhibitors
- has_mesh
- serineproteaseinhibitors
- has_atc
- c10axotherlipidmodifyingagents